M&A
Asia Healthcare Holdings to acquire Dr Dangs Labs
Asia Healthcare Holdings (AHH), backed by Singapore’s sovereign wealth fund GIC, is set to acquire a majority stake in Dr Dangs Labs , a diagnostic chain operating in Delhi and Gurugram. This marks the fourth acquisition by AHH, following previous deals with Motherhood Hospitals, the Asian Institute of Nephrology and Urology (AINU), and Nova IVF.Dr Dangs Labs operates seven centres across Delhi and Gurugram and reported a revenue of INR 67.7 crore for the financial year ended 31 March 2024.AHH’s earlier investment in AINU in 2023, valued at INR 600 crore, involved both primary and secondary funding. AHH received USD 150 million from GIC in December 2024, which made the sovereign fund the largest shareholder in the company. GIC had also invested USD 170 million in AHH in February 2022.
Want to receive such news items in your inbox? Click Here to sign up for a trial.
